Suwon, South Korea

Inhee Lee

This inventor holds 1 USPTO granted patent. Top assignee: Choongwae Pharma Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inhee Lee. Retrieved from https://idiyas.com/inventor/inhee-lee-6fxnm1q6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inhee Lee: Innovator in Pharmaceutical Chemistry

Introduction

Inhee Lee is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of chiral intermediates for therapeutic agents.

Latest Patents

Inhee Lee holds a patent for a process related to the preparation of optically active 2-[6-(substituted alkyl)-1,3-dioxan-4-yl]acetic acid derivatives. This invention involves a new process for preparing a key chiral intermediate compound, which is essential for creating therapeutic agents for hyperlipidemia, such as Astrovastatin and Fluvastatin. The patent outlines the use of various chemical compounds and their configurations, showcasing Lee's expertise in complex organic synthesis.

Career Highlights

Inhee Lee is currently associated with Choongwae Pharma Corporation, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new processes and compounds that can lead to more effective treatments for various health conditions.

Collaborations

Inhee Lee collaborates with fellow researcher Seungjoo Lee, enhancing the scope and impact of their work in the pharmaceutical industry.

Conclusion

Inhee Lee's contributions to pharmaceutical chemistry, particularly through his patented processes, highlight his role as an influential inventor in the field. His ongoing work at Choongwae Pharma Corporation continues to pave the way for advancements in therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…